Decreases in protease nexins in Alzheimer's disease brain
- PMID: 8544905
- DOI: 10.1016/0197-4580(95)00060-r
Decreases in protease nexins in Alzheimer's disease brain
Abstract
A marked and significant reduction of protease nexin-1 (PN-1) and PN-2/amyloid beta protein precursor (A beta PP) was observed in selected regions of Alzheimer's disease (AD) brains as compared to those of aged-matched controls. Correlative analysis indicated a relationship between PN-1 reduction and the severity of pathologic alterations. A statistically significant inverse correlation was noted between the level of PN-1 activity and the density of tau-positive dystrophic neurites in the hippocampus. In view of the ability of thrombin and PN-1 activity to regulate neurite outgrowth, it is possible that abnormal thrombin and PN-1 interactions may play a role in dystrophic neurite formation. The presence of clusters of dystrophic neurites around the capillaries suggests that blood-brain barrier (BBB) dysfunction may enhance such abnormal interactions. The decrease in PN-2/A beta PP levels in AD brains could possibly contribute to neuronal degeneration in AD in view of the ability of PN-2/A beta PP to protect neurons against the toxic effects of the A beta.
Similar articles
-
Protease nexin-1, a potent thrombin inhibitor, is reduced around cerebral blood vessels in Alzheimer's disease.Brain Res. 1994 Dec 30;668(1-2):160-70. doi: 10.1016/0006-8993(94)90521-5. Brain Res. 1994. PMID: 7704602
-
Protease nexin-1, an antithrombin with neurite outgrowth activity, is reduced in Alzheimer disease.Proc Natl Acad Sci U S A. 1989 Nov;86(21):8284-8. doi: 10.1073/pnas.86.21.8284. Proc Natl Acad Sci U S A. 1989. PMID: 2813392 Free PMC article.
-
Platelet protease nexin-2/amyloid beta-protein precursor. Possible pathologic and physiologic functions.Ann N Y Acad Sci. 1991;640:140-4. doi: 10.1111/j.1749-6632.1991.tb00205.x. Ann N Y Acad Sci. 1991. PMID: 1776731 Review.
-
Protease nexin-1. Localization in the human brain suggests a protective role against extravasated serine proteases.Am J Pathol. 1990 Oct;137(4):741-7. Am J Pathol. 1990. PMID: 2221008 Free PMC article.
-
Regulation of neuronal cells and astrocytes by protease nexin-1 and thrombin.Ann N Y Acad Sci. 1992 Dec 31;674:228-36. doi: 10.1111/j.1749-6632.1992.tb27491.x. Ann N Y Acad Sci. 1992. PMID: 1288365 Review. No abstract available.
Cited by
-
Cycle on Wheels: Is APP Key to the AppBp1 Pathway?Austin Alzheimers Parkinsons Dis. 2014;1(2):id1008. Austin Alzheimers Parkinsons Dis. 2014. PMID: 25568892 Free PMC article.
-
Proteinases and signalling: pathophysiological and therapeutic implications via PARs and more.Br J Pharmacol. 2008 Mar;153 Suppl 1(Suppl 1):S263-82. doi: 10.1038/sj.bjp.0707507. Epub 2007 Dec 3. Br J Pharmacol. 2008. PMID: 18059329 Free PMC article. Review.
-
Putative autoantibodies in the cerebrospinal fluid of Alzheimer's disease patients.F1000Res. 2019 Nov 11;8:1900. doi: 10.12688/f1000research.21140.1. eCollection 2019. F1000Res. 2019. PMID: 32089828 Free PMC article.
-
Spatial RNA Sequencing Identifies Robust Markers of Vulnerable and Resistant Human Midbrain Dopamine Neurons and Their Expression in Parkinson's Disease.Front Mol Neurosci. 2021 Jul 8;14:699562. doi: 10.3389/fnmol.2021.699562. eCollection 2021. Front Mol Neurosci. 2021. PMID: 34305528 Free PMC article.
-
The effects of trypsin on rat brain astrocyte activation.Iran J Neurol. 2013;12(4):129-35. Iran J Neurol. 2013. PMID: 24250922 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous